×
Hero Background

Evans Syndrome Companies

ID: MRFR/LS/3700-HCR
85 Pages
Rahul Gotadki
October 2025

In the field of autoimmune disorders, Evans Syndrome companies focus on developing targeted therapies and interventions. These organizations aim to improve the understanding and management of Evans Syndrome, contributing to better patient outcomes.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Evans Syndrome Market Research Report - Global Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Evans Syndrome Market

Evans Syndrome Market

 


Latest Evans Syndrome Companies Updates:


Apellis Pharmaceuticals: Acquired Tioma Therapeutics, gaining access to their promising complement inhibitor for treating rare blood diseases, including Evans syndrome.


Travere Biopharmaceuticals: Partnered with Akcea Therapeutics to develop and commercialize pegcetacoplan for treating certain blood diseases, including Evans syndrome.


List of Evans Syndrome Key companies in the market:



  • Pfizer, Merck & Co.

  • Sanofi

  • Astellas Pharma, Inc.

  • GlaxoSmithKline plc

  • Novartis AG

  • Enzon Pharmaceuticals, Inc.

  • Bayer AG

  • Sigma-Aldrich

  • Abbott Laboratories

  • Eli Lily and Company

  • BD

  • ChemoMetec A/S